DXCM:NASDAQ
DexCom Inc
$88.02
arrow_upward
+1.82%(+1.57) 1D
Sep 16, 10:37:33 AM GMT-4 · USD
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for DXCM...
Open
$86.05
High
$88.60
Low
$86.05
Mkt. cap
33.22B
Avg. vol.
4.31M
Volume
528.01K
P/E ratio
34.92
52-wk high
$92.59
52-wk low
$54.11
EPS
$2.52
Beta
1.42
Shares outstanding
377.36M
No. of employees
11K
Open
$86.05
High
$88.60
Low
$86.05
Mkt. cap
33.22B
Avg. vol.
4.31M
Volume
528.01K
P/E ratio
34.92
52-wk high
$92.59
52-wk low
$54.11
EPS
$2.52
Beta
1.42
Shares outstanding
377.36M
No. of employees
11K
News stories
From web sources and news partners
ad-hoc-news.de
·
5 hours ago
Dexcom Inc. stock gains as leadership shift and FDA pilot highlight growth ambitions
News Corp
·
17 hours ago
DexCom Inc. stock outperforms competitors on strong trading day
MarketWatch
·
17 hours ago
DexCom Inc. stock outperforms competitors on strong trading day
Simply Wall Street
·
1 day ago
DexCom (DXCM) Appoints Former Medtech Finance Chief Glenn Boehnlein To Board
Profile
Dexcom, Inc. is an American multinational healthcare company that develops, manufactures, produces and distributes a line of continuous glucose monitoring systems for diabetes management. It operates internationally with global headquarters and R&D center in San Diego, California, U.S., and manufacturing facilities in Mesa, Arizona, U.S.; Batu Kawan, Malaysia; and Athenry, County Galway, Ireland. Wikipedia
About DexCom Inc
CEO-
Employees11K
Founded1999
HeadquartersSan Diego, California, United States
SectorMedical device
Websitedexcom.com